(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes-Reference-Cited by-同舟云学术

(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes

Published:2017 Issue:32 Volume:23 Page:5895
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Wang Yi-Zhong,Li Jie-Liang,Wang Xu,Zhang Ting,Ho Wen-Zhe

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference46 articles.

1. Hepatitis C virus infection

2. Recent advances in understanding hepatitis C

3. Prevention of spread of hepatitis C

4. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:47-52.

5. Battaglia AM, Hagmeyer KO. Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection. Ann Pharmacother 2000;34:487-494.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma;Frontiers in Pharmacology;2023-05-24

2. The medicinal value of tea drinking in the management of COVID-19;Heliyon;2023-01

3. A Review of Procyanidin: Updates on Current Bioactivities and Potential Health Benefits;Biointerface Research in Applied Chemistry;2021-10-24

4. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives;Biomolecules;2021-08-23

5. (-)-Epigallocatechin-3-gallate induces interferon-λ2 expression to anti-influenza A virus in human bronchial epithelial cells (BEAS-2B) through p38 MAPK signaling pathway;Journal of Thoracic Disease;2020-03